Table 2.
Research on intervention compound related to lactate metabolic enzymes, lactate transporters, lactate writing proteins and erasing proteins.
| Compound | Action | Influence | Research on kidney | References |
|---|---|---|---|---|
| Related to lactate metabolic enzymes | ||||
| 2-DG | Inhibition of glycolysis(Usually HK is suppressed) | Promote autophagy through lactate/SIRT3/AMPK pathway to prevent AKI | Yes | 96 |
| AST-120 | Inhibit HK2 | Inhibition of lactate production alleviates AKI, while further inhibiting HK by attenuating H3K18 lactylation | Yes | 70 |
| Shikonin | Inhibit PKM2 | Reducing lactate production and H3K18 lactylation attenuates renal fibrosis and inhibits the MMT process by downregulating TGF-β1 expression | Yes | 68 |
| GSK2837808A | Inhibit LDH | Reduce lactate production, reduce 3-typ-mediated FIS1 K20 lactylation, and alleviate AKI | Yes | 67 |
| DCA | Activate PDH | Activation of PDHA1 reduces lactate production, thereby reducing FIS1 K20 lactylation and reducing AKI | Yes | 67 |
| DML | Inhibit LDH | Inhibiting lactate production to suppress H3K9 and H3K56 lactylation, thereby alleviating HCC | No | 95 |
| Related to lactate transporters | ||||
| AZD3965 | Inhibit MCT1 | Inhibition of lactate efflux leads to lactate accumulation and thus inhibits lymphoma growth | No | 98 |
| BAY-8002 | Inhibit MCT1 | Inhibition of lactate efflux leads to lactate accumulation and thus inhibits lymphoma growth | No | 99 |
| Related to lactate writing proteins and erasing proteins | ||||
| garcinol | Inhibit p300 | Inhibition of acetylation to inhibit oxidative stress, inflammation and tubular cell death to inhibit AKI | Yes | 101 |
| A485 | Inhibit p300 | Inhibit the lactylation of YY1 K183, thereby inhibiting FGF2 transcription and then inhibiting angiogenesis | No | 103 |
| C646 | Inhibit p300 | Inhibit the lactylation of HMGB1 | No | 102 |
| Honokiol | Activate SIRT3 | Promote the delactylation of CCNE2 K348 and then inhibit HCC | No | 60 |
2-DG: 2-Deoxy-D-Glucose; HK: Hexokinase; SIRT3: Sirtuin 3; AMPK: Adenosine Monophosphate-Activated Protein Kinase; AKI: AKI; HK2: Hexokinase 2; H3K18: Histone H3 Lysine 18; PKM2: Pyruvate Kinase M2; MMT: Mesenchymal-Myofibroblast Transition; TGF-β1: Transforming Growth Factor-Beta 1; LDH: Lactate Dehydrogenase; DCA: Dichloroacetate; PDH: Pyruvate Dehydrogenase; PDHA1: Pyruvate Dehydrogenase E1 Alpha Subunit 1; FIS1: Mitochondrial Fission 1 Protein; DML: Demethylzeylasteral; H3K9: Histone H3 Lysine 9; H3K56: Histone H3 Lysine 56; HCC: Hepatocellular Carcinoma; MCT1: Monocarboxylate Transporter 1; p300: E1A Binding Protein P300; YY1: Yin Yang 1; FGF2: Fibroblast Growth Factor 2; HMGB1: High Mobility Group Box 1; CCNE2: Cyclin E2.